Stat News
STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs

Bristol Myers Squibb and China's Hengrui Pharma are teaming up to advance more than a dozen early-stage drugs, in a deal worth up to $15.2 billion.
S
Source
Stat News
Read full article at Stat News
Opens original article in a new tab
Advertisement



